PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 6/2
Copy link
Facebook
Email
Notes
More

Market Analysis and Trades for 6/2

PharmD_KS's avatar
PharmD_KS
Jun 01, 2025
∙ Paid
9

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 6/2
Copy link
Facebook
Email
Notes
More
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

SPY 0.00%↑

We had entered puts on the pop into Thursday’s close and got a nice liquidation on Friday which resolved nearly 80 handles from that entry. However, as discussed in the weekly plan, this is a two-way tape for now where attempts at range expansion to either side have been firmly rejected. Sellers briefly took out Tuesday’s cash hours low, getting into the gap but didn’t quite make it to the major weekly pivot (then 5841-5851) and were unable/unwilling to defend any of the key levels from below. Thus, we saw reversion right back to 5925 ES as expected. From Thursday night’s plan:

This may seem maddening (especially if short) but it is a very standard reversion trade based on how the week’s profile had developed. It does seem that the market is coiled for a directional move, but until then we trade a two-way tape.

Paid Content Below or in the Discord

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More